| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1238697-26-1 | Balipodect(TAK-063) |
| | 询价 |
| 2 | 110331-06-1 | m-Anisidine,4-((7-phenoxyheptyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 15382-78-2 | m-Anisidine,4-((8-phenyloctyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 15382-76-0 | m-Anisidine,4-((6-phenylhexyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 15382-79-3 | m-Anisidine,4-((5-p-tolylpentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 13123-84-7 | m-Anisidine,4-((5-(p-nitrophenyl)pentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 15382-81-7 | m-Anisidine,4-((5-(p-methoxyphenyl)pentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 107779-28-2 | m-Anisidine,4-((5-(phenylthio)pentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 15382-75-9 | m-Anisidine,4-((5-phenylpentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 108240-29-5 | m-Anisidine,4-((5-((p-chlorophenyl)thio)pentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 107779-32-8 | m-Anisidine,4-((5-phenoxypentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 106271-06-1 | m-Anisidine,4-((5-(methylsulfonyl)pentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 15382-70-4 | m-Anisidine,4-((5-cyclohexylpentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 15382-74-8 | m-Anisidine,4-(4-phenylbutoxy)-,methanesulfonate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 1230-77-9 | MAO-B inhibitor C5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 1619884-75-1 | MAO-B Inhibitor 58 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 122871-01-6 | Manninotrionate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 109940-06-9 | m-Anisidine,N-methyl-4-((5-phenylpentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 13123-90-5 | m-Anisidine,N,N-dimethyl-4-((5-phenylpentyl)oxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 94238-43-4 | BPD-B-1,4-diene |
≥98% | | 询价 |
| 21 | 137525-51-0 | BPC 157 |
≥98% | | 询价 |
| 22 | 849776-40-5 | BPC Hydroiodide |
≥98% | | 询价 |
| 23 | 1622060-51-8 | BP13944 |
≥98% | | 询价 |
| 24 | 35193-18-1 | Lysyl-tyrosyl-lysine |
≥98% | | 询价 |
| 25 | 1207993-83-6 | Bozepinib |
≥98% | | 询价 |
| 26 | 113760-29-5 | BOT-64 |
≥98% | | 询价 |
| 27 | 471-66-9 | Boswellic acid |
≥98% | | 询价 |
| 28 | 77671-31-9 | Enoximone |
≥98% | | 询价 |
| 29 | 1226213-83-7 | PDAT |
≥98% | | 询价 |
| 30 | 80994-59-8 | Borofalan |
≥98% | | 询价 |
| 31 | 20448-86-6 | Bornaprine |
≥98% | | 询价 |
| 32 | 82857-38-3 | Bopindolol Malonate |
≥98% | | 询价 |
| 33 | 32986-56-4 | Tobramycin |
≥98% | | 询价 |
| 34 | 40830-74-8 | MNIP |
≥98% | | 询价 |
| 35 | 1947348-42-6 | BOP sodium salt |
≥98% | | 询价 |
| 36 | 330784-47-9 | Avanafil(TA1790) |
| | 询价 |
| 37 | 217453-20-8 | BOP |
≥98% | | 询价 |
| 38 | 1702-17-6 | Clopyralid |
≥98% | | 询价 |
| 39 | 354784-03-5 | BoNT-IN-33 |
≥98% | | 询价 |
| 40 | 95648-98-9 | Bombolitin V |
≥98% | | 询价 |
| 41 | 1491-81-2 | Bolmantalate |
≥98% | | 询价 |
| 42 | 476-70-0 | Boldine |
≥98% | | 询价 |
| 43 | 846-48-0 | Boldenone |
≥98% | | 询价 |
| 44 | 82626-01-5 | Alpidem |
| 5mg, 10mg, 50mg | 询价 |
| 45 | 1010879-39-6 | MAO-B ligand-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 33600-93-0 | Maytenonic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 796073-69-3 | Maytansinoid DM4 |
≥98% | | 询价 |
| 48 | 35846-53-8 | Maytansine |
≥98% | | 询价 |
| 49 | 136470-78-5 | Abacavir |
| | 询价 |
| 50 | 3736-77-4 | 2,2'-Anhydrouridine |
| 100mg | 询价 |
| 51 | 71751-41-2 | Avermectin B1(AbamectinAvermectin B1a-Avermectin B1b mixt,) |
| 100mg | 询价 |
| 52 | 70255-49-1 | Maysin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 305376-89-0 | MssL-IN-2I |
≥98% | | 询价 |
| 54 | 1776112-90-3 | Mavelertinib(PF06747775) |
≥98% | | 询价 |
| 55 | 170569-88-7 | Mavacoxib(PHA-739521) |
≥98% | | 询价 |
| 56 | 1642288-47-8 | Mavacamten(SAR-439152 MYK-461) |
≥98% | | 询价 |
| 57 | 109008-28-8 | Mauritianin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 140626-94-4 | Matlystatin A |
≥98% | | 询价 |
| 59 | 6138-94-9 | Masticadienediol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | | VUF16216 |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com